Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription Articles published in PLoS Pathog Retrieve available abstracts of 37 articles: HTML format

Single Articles

February 2026
1. PAESEN GC, Chapman NS, Westover JB, McMillen CM, et al
   Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain.
   PLoS Pathog. 2026;22:e1013926.
   PubMed     Abstract available
   
   
   January 2026
2. MATSUZAWA K, Ekimoto T, Kobayashi C, Shionoya K, et al
   Structural mapping of NTCP distinguishes its dual functionality as a hepatitis B virus receptor and bile acid transporter.
   PLoS Pathog. 2026;22:e1013824.
   PubMed     Abstract available
   
   
   December 2025
3. WANG Y, Wu S, Li X, Qiao L, et al
   Antiviral and immune modulatory activities of STING agonists in a mouse model of persistent hepatitis B virus infection.
   PLoS Pathog. 2025;21:e1013709.
   PubMed     Abstract available
   
   
   
4. GUNAWARDENE CD, Pandey I, Chatterjee S, Penaflor-Tellez Y, et al
   Heterologous expression of HCoV-HKU1 ORF 7b by mouse hepatitis virus protects against severe disease during murine infection.
   PLoS Pathog. 2025;21:e1013148.
   PubMed     Abstract available
   
   
   
5. WANG Y, Murai K, Ishida A, Kawasaki N, et al
   Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infection.
   PLoS Pathog. 2025;21:e1013776.
   PubMed     Abstract available
   
   
   November 2025
6. MEESTER M, Valenzuela Agui C, Tobias TJ, Guinat C, et al
   Zoonotic hepatitis E virus spreads through environmental routes in pig herds-A phylodynamic analysis.
   PLoS Pathog. 2025;21:e1013710.
   PubMed     Abstract available
   
   
   September 2025
7. THORSELIUS CE, Kok A, Fahnoe U, Wolfisberg R, et al
   In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirus.
   PLoS Pathog. 2025;21:e1013127.
   PubMed     Abstract available
   
   
   
8. MEHNERT AK, Stegmaier S, Ramirez Alvarez C, Toprak E, et al
   The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistent replication in cell culture.
   PLoS Pathog. 2025;21:e1013516.
   PubMed     Abstract available
   
   
   
9. SCHWOERER MP, Carver S, Lin AE, Liu J, et al
   Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells.
   PLoS Pathog. 2025;21:e1013412.
   PubMed     Abstract available
   
   
   August 2025
10. XU Z, Zhao K, Wang J, Zhang L, et al
    Screening of different species reveals cat hepatocytes support HBV infection.
    PLoS Pathog. 2025;21:e1013390.
    PubMed     Abstract available
    
    
    April 2025
11. ZHAO L, Hall M, Giridhar P, Ghafari M, et al
    Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure.
    PLoS Pathog. 2025;21:e1012959.
    PubMed     Abstract available
    
    
    March 2025
12. SOERENSEN A, Popovic F, Olesen CH, Mendez BL, et al
    Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies.
    PLoS Pathog. 2025;21:e1012428.
    PubMed     Abstract available
    
    
    February 2025
13. ZHANG H, Long Q, Liu Y, Marchetti AL, et al
    Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation.
    PLoS Pathog. 2025;21:e1012918.
    PubMed     Abstract available
    
    
    
14. HSIEH CL, Chang LY, Chen PJ, Yeh SH, et al
    HBV polymerase recruits the phosphatase PP1 to dephosphorylate HBc-Ser170 to complete encapsidation.
    PLoS Pathog. 2025;21:e1012905.
    PubMed     Abstract available
    
    
    
15. BRADLEY DP, Valkner CJ, Li Q, Gasonoo M, et al
    Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors.
    PLoS Pathog. 2025;21:e1012920.
    PubMed     Abstract available
    
    
    January 2025
16. ZHAO K, Wang J, Wang Z, Wang M, et al
    Hepatitis B virus hijacks MRE11-RAD50-NBS1 complex to form its minichromosome.
    PLoS Pathog. 2025;21:e1012824.
    PubMed     Abstract available
    
    
    
17. YU L, Chang H, Xie W, Zheng Y, et al
    Manganese is a potent inducer of lysosomal activity that inhibits de novo HBV infection.
    PLoS Pathog. 2025;21:e1012800.
    PubMed     Abstract available
    
    
    
18. ZHANG M, Mouzannar K, Zhang Z, Teraoka Y, et al
    Hepatitis B virus genotypes A1 and A2 have distinct replication phenotypes due to polymorphisms in the HBx gene.
    PLoS Pathog. 2025;21:e1012803.
    PubMed     Abstract available
    
    
    
19. QIU Q, He Z, Liu J, Xu H, et al
    Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.
    PLoS Pathog. 2025;21:e1012897.
    PubMed     Abstract available
    
    
    October 2024
20. LOPEZ-SCARIM J, Mendoza D, Nambiar SM, Billerbeck E, et al
    CD4+ T cell help during early acute hepacivirus infection is critical for viral clearance and the generation of a liver-homing CD103+CD49a+ effector CD8+ T cell subset.
    PLoS Pathog. 2024;20:e1012615.
    PubMed     Abstract available
    
    
    September 2024
21. REICHERT I, Lee JY, Weber L, Fuh MM, et al
    The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.
    PLoS Pathog. 2024;20:e1012509.
    PubMed     Abstract available
    
    
    
22. SHEN S, Cai D, Liang H, Zeng G, et al
    NEDD4 family ubiquitin ligase AIP4 interacts with Alix to enable HBV naked capsid egress in an Alix ubiquitination-independent manner.
    PLoS Pathog. 2024;20:e1012485.
    PubMed     Abstract available
    
    
    June 2024
23. GRIESMAN T, McMillen CM, Negatu SG, Hulahan JJ, et al
    The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis.
    PLoS Pathog. 2024;20:e1012343.
    PubMed     Abstract available
    
    
    May 2024
24. YADAV KK, Boley PA, Laocharoensuk T, Khatiwada S, et al
    Infectious hepatitis E virus is associated with the mature sperm head.
    PLoS Pathog. 2024;20:e1012240.
    PubMed     Abstract available
    
    
    
25. CAMPS G, Maestro S, Torella L, Herrero D, et al
    Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.
    PLoS Pathog. 2024;20:e1011749.
    PubMed     Abstract available
    
    
    March 2024
26. MATSUDA M, Hirai-Yuki A, Kotani O, Kataoka M, et al
    Loxapine inhibits replication of hepatitis A virus in vitro and in vivo by targeting viral protein 2C.
    PLoS Pathog. 2024;20:e1012091.
    PubMed     Abstract available
    
    
    
27. LI Y, Wu C, Lee J, Ning Q, et al
    Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages.
    PLoS Pathog. 2024;20:e1012079.
    PubMed     Abstract available
    
    
    
28. KHALFI P, Denis Z, McKellar J, Merolla G, et al
    Comparative analysis of human, rodent and snake deltavirus replication.
    PLoS Pathog. 2024;20:e1012060.
    PubMed     Abstract available
    
    
    
29. PETRACCIONE K, Ali MGH, Cyr N, Wahba HM, et al
    An LIR motif in the Rift Valley fever virus NSs protein is critical for the interaction with LC3 family members and inhibition of autophagy.
    PLoS Pathog. 2024;20:e1012093.
    PubMed     Abstract available
    
    
    February 2024
30. BENDER D, Koulouri A, Wen X, Glitscher M, et al
    Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus.
    PLoS Pathog. 2024;20:e1011976.
    PubMed     Abstract available
    
    
    
31. ZHENG Y, Wang M, Yin J, Duan Y, et al
    Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export.
    PLoS Pathog. 2024;20:e1011999.
    PubMed     Abstract available
    
    
    January 2024
32. TSUKUDA S, Harris JM, Magri A, Balfe P, et al
    The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
    PLoS Pathog. 2024;20:e1011917.
    PubMed     Abstract available
    
    
    December 2023
33. FENG J, Xu T, He M, Li J, et al
    NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.
    PLoS Pathog. 2023;19:e1011808.
    PubMed     Abstract available
    
    
    
34. SO CW, Sourisseau M, Sarwar S, Evans MJ, et al
    Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
    PLoS Pathog. 2023;19:e1011887.
    PubMed     Abstract available
    
    
    November 2023
35. CARRIQUI-MADRONAL B, Sheldon J, Duven M, Stegmann C, et al
    The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.
    PLoS Pathog. 2023;19:e1011759.
    PubMed     Abstract available
    
    
    October 2023
36. DRAVID P, Murthy S, Attia Z, Cassady C, et al
    Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection.
    PLoS Pathog. 2023;19:e1011697.
    PubMed     Abstract available
    
    
    September 2023
37. SUBRAMANIAM S, Fares-Gusmao R, Sato S, Cullen JM, et al
    Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils.
    PLoS Pathog. 2023;19:e1011664.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum